Comparison of the pathological response to 2 or 4 cycles of neoadjuvant CAPOX in II/III rectal cancer patients with low/intermediate risks: study protocol for a prospective, non-inferior, randomized control trial (COPEC trial)

BACKGROUND: For patients with low- and intermediate-risk stage II/III rectal cancer, current studies have reached a consensus that preoperative radiotherapy may be dispensed with, and neoadjuvant chemotherapy (NCT) alone might achieve an accepted local control. Our previous phase II study has eviden...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Yu, Shi, Wanyue, Huang, Cui, Gong, Xiaoling, Wei, Mingtian, Meng, Wenjian, Deng, Xiangbing, Wang, Ziqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262432/
https://www.ncbi.nlm.nih.gov/pubmed/37312165
http://dx.doi.org/10.1186/s13063-023-07405-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262432/
https://www.ncbi.nlm.nih.gov/pubmed/37312165
http://dx.doi.org/10.1186/s13063-023-07405-x

Ejemplares similares